Emcure Pharmaceuticals Limited is an Indian multinational pharm... - dofaq.co
Emcure Pharmaceuticals Limited is an Indian multinational pharm...
wikipedia - 09 Feb 2022
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Pune, Maharashtra. Emcure's product portfolio includes tablets, capsules (both Softgel capsules and hard-gel capsules) and injectables.[1][2]
India's Emcure Pharma plans 2024 IPO, hires JP Morgan, Jefferies- sources
Reuters - 25 Sep 2023
India's Emcure Pharma plans 2024 IPO, hires JP Morgan, Jefferies- sources ...
Namita Thapar shuts down troll who asked: ‘if daddy’s money hadn’t been there…’
Moneycontrol - 13 Mar 2024
Namita Thapar shuts down troll who asked: ‘if daddy’s money hadn’t been there…’ ...
Sanofi India, Emcure Pharma announce exclusive distribution partnership
Business Standard - 13 Mar 2024
Sanofi India, Emcure Pharma announce exclusive distribution partnership ...
‘Daddy’s money?’ Emcure director Namita Thapar shuts down doubts during Reddit AMA
The Indian Express - 13 Mar 2024
‘Daddy’s money?’ Emcure director Namita Thapar shuts down doubts during Reddit AMA ...
Emcure to distribute Sanofi India’s cardiovascular brands
BusinessLine - 13 Mar 2024
Emcure to distribute Sanofi India’s cardiovascular brands ...
'Shark Tank India' judge Namita Thapar candidly opens up about perimenopause struggles during show: Watch
The Economic Times - 06 Mar 2024
'Shark Tank India' judge Namita Thapar candidly opens up about perimenopause struggles during show: Watch ...
Rs 20 lakh shoes, Rs 50 crore mansion, luxurious cars, and Rs 600 crore net worth – Meet Namita Thapar, Executive Director of Emcure Pharma and Shark Tank India judge
The Financial Express - 22 Mar 2024
Rs 20 lakh shoes, Rs 50 crore mansion, luxurious cars, and Rs 600 crore net worth – Meet Namita Thapar, Executive Director of Emcure Pharma and Shark Tank India judge ...
Emcure Pharma plans to launch $400-500 million IPO in 2024, hires Kotak, Jefferies for it | Mint
Mint - 25 Sep 2023
Emcure Pharma plans to launch $400-500 million IPO in 2024, hires Kotak, Jefferies for it | Mint ...
Emcure wins dismissal of US lawsuit over COVID-19 vaccine trade secrets
Reuters - 05 Dec 2023
Emcure wins dismissal of US lawsuit over COVID-19 vaccine trade secrets ...
Net Worth To Car Collection, All About Emcure Pharmaceuticals' Executive Director Namita Thapar
News18 - 15 Mar 2024
Net Worth To Car Collection, All About Emcure Pharmaceuticals' Executive Director Namita Thapar ...
MPW 2023: Here’s why Emcure Pharmaceuticals’ Namita Thapar just loves her business
Business Today - 12 Dec 2023
MPW 2023: Here’s why Emcure Pharmaceuticals’ Namita Thapar just loves her business ...
U.S. Court Dismisses Lawsuit Against Emcure Over Covid-19 Vaccine
NDTV Profit - 06 Dec 2023
U.S. Court Dismisses Lawsuit Against Emcure Over Covid-19 Vaccine ...
Sanofi India inks distribution pact with Emcure, but shares trade flat
TradingView - 14 Mar 2024
Sanofi India inks distribution pact with Emcure, but shares trade flat ...
Sanofi India broadens reach of cardiovascular brands in partnership with Emcure Pharma
BSI bureau - 13 Mar 2024
Sanofi India broadens reach of cardiovascular brands in partnership with Emcure Pharma ...
Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fame
The Economic Times - 11 Feb 2024
Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fame ...
Bain Capital-backed Emcure Pharmaceuticals refiles IPO papers with reduced issue size
Moneycontrol - 17 Dec 2023
Bain Capital-backed Emcure Pharmaceuticals refiles IPO papers with reduced issue size ...
Emcure boss Namita Thapar thanks trolls for making her ‘more thick-skinned’ | Mint
Mint - 14 Mar 2024
Emcure boss Namita Thapar thanks trolls for making her ‘more thick-skinned’ | Mint ...
Emcure Pharma gets relief in $950-million lawsuit
The Economic Times - 06 Dec 2023
Emcure Pharma gets relief in $950-million lawsuit ...
Sanofi ties up with Emcure to broaden reach of cardiovascular brands
Moneycontrol - 13 Mar 2024
Sanofi ties up with Emcure to broaden reach of cardiovascular brands ...